Compare Halozyme Therapeutics Inc. Common Stock (HALO) vs Nova Ltd (NVMI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Halozyme Therapeutics Inc. Common Stock vs Nova Ltd — how do they compare? Halozyme Therapeutics Inc. Common Stock trades at $110.42 (market cap $12.58B), while Nova Ltd trades at $353 (market cap $11.28B). The key difference: Halozyme Therapeutics Inc. Common Stock and Nova Ltd are close in size by market cap, and Halozyme Therapeutics Inc. Common Stock is trading nearer its 52-week high, Nova Ltd nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Halozyme Therapeutics Inc. Common Stock for 1 Days and Nova Ltd for 4 Days on average.
| HALO | NVMI | |
|---|---|---|
Market Cap | $12.58B | $11.28B |
Volume | 2,179,278 | 394,997 |
Sector | Health | Technology |
52-Week High | $115.22 | $605.65 |
52-Week Low | $61.63 | $275.78 |
Typical Hold Time | 1 Days | 4 Days |
Enterprise Value | $14.49B | $11.06B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Halozyme Therapeutics Inc. Common Stock
Halozyme Therapeutics develops drug-delivery technologies for biopharmaceutical companies. Its ENHANZE technology uses the rHuPH20 enzyme to support subcutaneous delivery of co-administered medicines.
Read more on HALO →About Nova Ltd
Nova provides metrology solutions for semiconductor manufacturing. Its systems measure material and process characteristics to help chipmakers control production across advanced nodes and packaging.
Read more on NVMI →
